Prolonged Strait of Hormuz standoff and renewed Houthi strikes on Yemeni ports threaten to compound shipping delays and costs for drugmakers already navigating rerouted trade lanes. The prospects for a quick resolution to the Strait of Hormuz standoff dimmed further this weekend, with President Trump signaling the US is content to let economic pressure build on Iran rather than rush a deal, and Iran countering with a list of demands that would need to be met before the critical waterway reopens to normal traffic. For pharmaceutical supply chain and logistics teams, the standoff is no longer a background risk to monitor, it is shaping into a second front, layered on top of an already-strained Red Sea shipping corridor. Compounding the risk, Iranian-backed Houthi rebels struck the Yemeni port city of Mocha twice within 24 hours over the weekend, targeting what a Houthi military source described as weapons depots and troop concentrations, while Yemeni officials reported residential areas hit by missiles and drones as well.2 Mocha has served as an alternative port for shipping seeking to avoid the Houthi-held port of Hodeida.1For pharma supply chain leaders, the near-term implications include:Longer transit times as carriers continue routing around both the Red Sea and Gulf, adding time via the Cape of Good HopeElevated freight and marine insurance costs that flow through to landed cost of goodsContinued upward pressure on petrochemical-derived inputs, including excipients and packaging materials, tied to broader oil market volatilityHeightened sanctions and compliance exposure for companies or logistics partners with indirect Middle East freight exposure, should economic pressure on Iran intensify as Trump has suggestedNeither side signaled an imminent resolution. Trump characterized the standoff as a long game, telling Axios "it always works out," while Iran's list of conditions for reopening the strait suggests talks remain far from a deal.1 For pharmaceutical companies with Gulf- or Red Sea-adjacent sourcing or distribution, the practical takeaway is to treat the current routing and cost environment as the baseline for planning through the remainder of the year , rather than a temporary condition.